The Role of Circular RNAs in DNA Damage Response and Repair.

DNA damage response and repair (DDRR) circRNA double-strand breaks (DSB) tumorigenesis

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
26 Oct 2021
Historique:
received: 08 09 2021
revised: 15 10 2021
accepted: 15 10 2021
entrez: 13 11 2021
pubmed: 14 11 2021
medline: 14 11 2021
Statut: epublish

Résumé

Circular RNAs (circRNA) comprise a distinct class of non-coding RNAs that are abundantly expressed in the cell. CircRNAs have the capacity to regulate gene expression by interacting with regulatory proteins and/or other classes of RNAs. While a vast number of circRNAs have been discovered, the majority still remains poorly characterized. Particularly, there is no detailed information on the identity and functional role of circRNAs that are transcribed from genes encoding components of the DNA damage response and repair (DDRR) network. In this article, we not only review the available published information on DDRR-related circRNAs, but also conduct a bioinformatic analysis on data obtained from public repositories to uncover deposited, yet uncharacterized circRNAs derived from components of the DDRR network. Finally, we interrogate for potential targets that are regulated by this class of molecules and look into potential functional implications.

Identifiants

pubmed: 34771517
pii: cancers13215352
doi: 10.3390/cancers13215352
pmc: PMC8582540
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : Hellenic Foundation for Research and Innovation
ID : 775, 3782
Organisme : National Public Investment Program of the Ministry of Development and Investment/General Secretariat for Research and Technology
ID : 2020ΣΕ01300001
Organisme : Greece and the European Union (European Social Fund- ESF), State Scholarships Foundation (ΙΚΥ)
ID : MIS-5033021
Organisme : Welfare Foundation for Social & Cultural Sciences (KIKPE)
ID : donation
Organisme : H. Pappas
ID : donation

Références

Cell Res. 2015 Aug;25(8):981-4
pubmed: 26138677
Biomolecules. 2021 Apr 09;11(4):
pubmed: 33918762
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Nat Biotechnol. 2014 May;32(5):453-61
pubmed: 24811520
Exp Gerontol. 2021 Feb;144:111178
pubmed: 33290860
Int J Biol Sci. 2021 Mar 2;17(4):1061-1078
pubmed: 33867829
Environ Pollut. 2019 Apr;247:64-71
pubmed: 30654255
Arch Toxicol. 2017 Apr;91(4):1671-1684
pubmed: 27604105
Nat Methods. 2015 Aug;12(8):767-72
pubmed: 26121403
Dose Response. 2019 Apr 22;17(2):1559325819837795
pubmed: 31040759
Mol Cancer. 2020 Aug 24;19(1):128
pubmed: 32838810
EMBO J. 2005 Apr 6;24(7):1465-76
pubmed: 15775963
Nature. 2020 Jul;583(7818):711-719
pubmed: 32728246
RNA Biol. 2015;12(4):381-8
pubmed: 25746834
BMC Bioinformatics. 2017 Jan 3;18(1):7
pubmed: 28049429
Science. 2017 Sep 22;357(6357):
pubmed: 28798046
J Radiat Res. 2004 Dec;45(4):473-8
pubmed: 15635255
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
PLoS One. 2012;7(2):e30733
pubmed: 22319583
J Cell Sci. 2013 Feb 15;126(Pt 4):889-903
pubmed: 23264744
Front Pharmacol. 2020 Mar 31;11:396
pubmed: 32300301
Cell Death Dis. 2020 Apr 24;11(4):280
pubmed: 32332801
Int J Mol Sci. 2018 Jul 17;19(7):
pubmed: 30018188
Mol Cell. 2017 Apr 6;66(1):22-37.e9
pubmed: 28344082
Blood. 2005 Jun 15;105(12):4776-83
pubmed: 15718417
Mol Cell. 2017 Jun 15;66(6):801-817
pubmed: 28622525
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Mutat Res Rev Mutat Res. 2015 Oct-Dec;766:1-19
pubmed: 26596544
Cell Rep. 2015 Jan 6;10(1):103-11
pubmed: 25543144
Cells. 2021 Jun 15;10(6):
pubmed: 34203749
Science. 2014 Mar 28;343(6178):1470-5
pubmed: 24675954
EMBO J. 2019 Feb 15;38(4):
pubmed: 30643021
Cell. 1998 May 1;93(3):477-86
pubmed: 9590181
Nat Commun. 2016 Apr 06;7:11215
pubmed: 27050392
BMC Genomics. 2017 Oct 3;18(Suppl 6):680
pubmed: 28984197
Nat Cell Biol. 2018 Mar;20(3):320-331
pubmed: 29403037
J Natl Cancer Inst. 2012 Oct 3;104(19):1470-84
pubmed: 22984202
PLoS One. 2016 Feb 05;11(2):e0148407
pubmed: 26848835
Breast Cancer Res Treat. 2021 Apr;186(2):305-316
pubmed: 33389400
Nucleic Acids Res. 2016 Apr 7;44(6):2846-58
pubmed: 26861625
Cell. 2019 Feb 7;176(4):831-843.e22
pubmed: 30735634
Nat Commun. 2017 Jun 01;8:15752
pubmed: 28569838
Trends Biochem Sci. 2015 May;40(5):248-56
pubmed: 25818326
Sci Rep. 2016 Aug 11;6:31313
pubmed: 27510448
Oncogene. 2018 Feb 1;37(5):555-565
pubmed: 28991235
Cancer Cell. 2008 Oct 7;14(4):324-34
pubmed: 18835034
Trends Cell Biol. 2020 Mar;30(3):226-240
pubmed: 31973951
J Exp Clin Cancer Res. 2021 Jan 5;40(1):6
pubmed: 33397440
Mol Cancer. 2019 Feb 4;18(1):20
pubmed: 30717751
Nucleic Acids Res. 2013 Sep;41(16):7589-605
pubmed: 23804754
Cell Res. 2019 Aug;29(8):628-640
pubmed: 31209250
Mol Cancer. 2018 Apr 7;17(1):79
pubmed: 29626935
Mol Cell Biol. 1997 Jun;17(6):2985-93
pubmed: 9154796
DNA Cell Biol. 2021 Jan;40(1):80-92
pubmed: 33202158
Signal Transduct Target Ther. 2020 May 1;5(1):60
pubmed: 32355263
Mol Ther Nucleic Acids. 2020 Mar 6;19:384-392
pubmed: 31887549
Prog Neurobiol. 2020 Mar;186:101746
pubmed: 31931031
Mol Cancer. 2020 Feb 15;19(1):30
pubmed: 32059672
Front Oncol. 2020 May 22;10:812
pubmed: 32670866
PLoS One. 2015 Jun 25;10(6):e0131225
pubmed: 26110611
Mol Cancer. 2019 Jun 22;18(1):111
pubmed: 31228937
Mol Cell. 2012 Apr 27;46(2):115-24
pubmed: 22541554
Cell. 2019 Feb 7;176(4):869-881.e13
pubmed: 30735636
Mol Cell Biol. 2020 Apr 13;40(9):
pubmed: 32041821
Theranostics. 2020 Feb 10;10(8):3503-3517
pubmed: 32206104
BMC Genomics. 2018 Jan 10;19(1):37
pubmed: 29321003
Cell Res. 2017 May;27(5):626-641
pubmed: 28281539
Mol Cell. 2015 Jun 4;58(5):870-85
pubmed: 25921068
Nucleic Acids Res. 2019 Nov 18;47(20):10678-10692
pubmed: 31501894
Biol Psychiatry. 2020 Feb 1;87(3):294-304
pubmed: 31570194
Nat Commun. 2015 Mar 09;6:6355
pubmed: 25751603
EMBO J. 2009 Sep 2;28(17):2503-10
pubmed: 19629047
Cell. 2013 Aug 1;154(3):490-503
pubmed: 23911317
Vet Dermatol. 2018 Oct;29(5):375-e126
pubmed: 29963730
Biomolecules. 2021 Jan 12;11(1):
pubmed: 33445626
Signal Transduct Target Ther. 2021 May 21;6(1):185
pubmed: 34016945
J Pathol. 2018 Sep;246(1):12-40
pubmed: 29756349
Pharmacol Ther. 2015 Oct;154:36-56
pubmed: 26145166
BMC Genomics. 2006 May 19;7:120
pubmed: 16712733
Mol Cell. 2010 Oct 22;40(2):179-204
pubmed: 20965415
PLoS One. 2012;7(2):e31870
pubmed: 22384090
RNA. 2013 Feb;19(2):141-57
pubmed: 23249747
Genes Dev. 1994 Aug 1;8(15):1739-49
pubmed: 7958853
Cell. 2016 Aug 11;166(4):1055-1056
pubmed: 27518567
Oncogene. 2016 Jul 28;35(30):3919-31
pubmed: 26657152
J Exp Clin Cancer Res. 2017 Oct 16;36(1):145
pubmed: 29037220
Genes Dev. 2015 Oct 15;29(20):2168-82
pubmed: 26450910
Sci Rep. 2016 Nov 28;6:37982
pubmed: 27892494
Am J Cancer Res. 2016 Jun 01;6(6):1167-76
pubmed: 27429839
Cells. 2021 Apr 10;10(4):
pubmed: 33920220
Mol Cell. 2014 Jan 9;53(1):7-18
pubmed: 24316220
Cell Discov. 2020 Aug 11;6:52
pubmed: 32818061
Nat Rev Genet. 2016 Jan;17(1):19-32
pubmed: 26593421
Cell Rep. 2015 Dec 15;13(10):2081-9
pubmed: 26628370
FASEB J. 1993 Jan;7(1):155-60
pubmed: 7678559
Cancer Lett. 2017 Jun 28;396:138-144
pubmed: 28342987
Oncogene. 2019 Aug;38(32):6017-6034
pubmed: 31300733
Front Mol Biosci. 2017 Jun 06;4:38
pubmed: 28634583
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211033075
pubmed: 34278876
Nat Commun. 2018 Feb 7;9(1):533
pubmed: 29416069
J Biol Chem. 2000 Mar 24;275(12):8945-51
pubmed: 10722742
EMBO J. 2019 Aug 15;38(16):e100836
pubmed: 31343080

Auteurs

Angelos Papaspyropoulos (A)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.
Biomedical Research Foundation, Academy of Athens, GR-11527 Athens, Greece.

Orsalia Hazapis (O)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.

Nefeli Lagopati (N)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.
Biomedical Research Foundation, Academy of Athens, GR-11527 Athens, Greece.

Aikaterini Polyzou (A)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.

Anastasios D Papanastasiou (AD)

Department of Biomedical Sciences, University of West Attica, GR-12462 Athens, Greece.
Histopathology Unit, Biomedical Sciences Research Center 'Alexander Fleming', GR-16672 Vari, Greece.

Michalis Liontos (M)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.
Oncology Unit, Department of Clinical Therapeutics, Medical School, National and Kapodistrian University of Athens, Alexandra Hospital, GR-11528 Athens, Greece.

Vassilis G Gorgoulis (VG)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.
Biomedical Research Foundation, Academy of Athens, GR-11527 Athens, Greece.
Molecular and Clinical Cancer Sciences, Manchester Cancer Research Centre, Manchester Academic Health Sciences Centre, University of Manchester, Manchester M20 4GJ, UK.
Center for New Biotechnologies and Precision Medicine, Medical School, National and Kapodistrian University of Athens, GR-11527 Athens, Greece.
Faculty of Health and Medical Sciences, University of Surrey, Surrey GU2 7YH, UK.

Athanassios Kotsinas (A)

Molecular Carcinogenesis Group, Department of Histology and Embryology, Medical School, National Kapodistrian University of Athens (NKUA), 75 Mikras Asias Str., Goudi, GR-11527 Athens, Greece.

Classifications MeSH